Abstract
Introduction: Some risks factors associated with COVID-19 infections were established such as coronary artery disease in patients with SARS-CoV-2 infections. The use of highly concentrated medications according to Arndt Schultz Law can induce reduction in the vital energy, leading to stagnation of Blood and propensity to have myocardial infarction even without arterial obstruction. Purpose: to demonstrate that patient with COVID-19 infection that received highly concentrated medications to treat this infection, have more propensity to develop myocardial infarction some days after the treatment instituted. Methods: through one case report of 42 years-old-male patient with history of acquired COVID-19 on January 2nd 2021. He was admitted in the hospital due to dyspnea symptoms, myalgia, and needs oxygenation. He received the medications, Ivermectin, Hydroxychloroquine, corticosteroids. After 18 days of the initial manifestations, the patient felt pain in the chest and went to the hospital and they found that his troponin was increasing gradually and after two hours of it increased many times and the physician decided to admit him again in the hospital to make more exams. The patient was submitted to catheterization and the result of this procedure were that all his coronary were in perfect state of health without any obstruction and they treated him as he had myocardial infarction. After three months, the patient went to my clinic due to post herpetic neuralgia and also to evaluate his condition and I performed the chakras’ energy centers measurement. Results: the results of this chakras’ energy centers measurement revealed that all his chakras were in the lowest level of energy (rated in one) with exception of the seventh (that was normal, rated in eight). I began his treatment using homeopathies medications according to the theory Constitutional Homeopathy of the Five Elements based on Traditional Chinese Medicine. Conclusion; the conclusion of this study is that patients treated with highly concentrated medications to treat SARS-CoV-2 infection can develop myocardial infarction even without arterial obstruction due to energy deficiency state prior to this infection and aggravated many times with to the use of any type of highly concentrated medications to treat this kind of infection, because it will reduce the vital energy that was already very low before the infection and will cause stagnation of Blood in any part of the body, in this case, inside the coronary artery.
Highlights
Some risks factors associated with COVID-19 infections were established such as coronary artery disease in patients with SARS-CoV-2 infections
[5] According to Hippocrates, “we need to consider ancient medical traditions prior to the knowledge we have nowadays”, so in this article, I will show the relationship between myocardial infarction development and SARS-CoV-2 infection, in the point of view of traditional Chinese medicine, taking into account, the possible energy imbalances presented by the patients prior to this SARS-CoV-2 infection, the type of medications used in the treatment of this infection that evolve to the development of myocardial infarction after this treatment. [3]
The purpose of this study is to demonstrate that patient that is having myocardial infarction after COVID-19 treatment is not related to the SARSCoV-2 itself but by the influences of the type of medication used in the treatment of patients with SARS-CoV-2 infection in a person that have energy deficiency in the internal five massive organs, demonstrated by the radiesthesia procedure
Summary
Some risks factors associated with COVID-19 infections were established such as coronary artery disease in patients with SARS-CoV-2 infections. Methods: through one case report of 42 years-old-male patient with history of acquired COVID-19 on January 2nd 2021 He was admitted in the hospital due to dyspnea symptoms, myalgia, and needs oxygenation. 375 bce) father of medicine, that said that “we need to treat the patient and not the disease.” [5] According to Hippocrates, “we need to consider ancient medical traditions prior to the knowledge we have nowadays”, so in this article, I will show the relationship between myocardial infarction development and SARS-CoV-2 infection, in the point of view of traditional Chinese medicine, taking into account, the possible energy imbalances presented by the patients prior to this SARS-CoV-2 infection, the type of medications used in the treatment of this infection that evolve to the development of myocardial infarction after this treatment. Myocardial injury is associated with a greater need for mechanical ventilator support and higher in-hospital mortality. [4] This article will be written by the influences of Hippocrates (c. 460 bce - c. 375 bce) father of medicine, that said that “we need to treat the patient and not the disease.” [5] According to Hippocrates, “we need to consider ancient medical traditions prior to the knowledge we have nowadays”, so in this article, I will show the relationship between myocardial infarction development and SARS-CoV-2 infection, in the point of view of traditional Chinese medicine, taking into account, the possible energy imbalances presented by the patients prior to this SARS-CoV-2 infection, the type of medications used in the treatment of this infection that evolve to the development of myocardial infarction after this treatment. [3]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical Cardiology and Cardiovascular Interventions
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
